Looking for a Strattera lawyer in Washington, DC? Get in touch with one of our Strattera lawyers in Washington, DC now.

Strattera

Strattera is a drug approved for the treatment of attention-deficit disorder with hyperactivity (ADHD) and considered by many to be a "safe" non-stimulant alternative to other ADHD drugs.  Manufactured by Eli-Lilly, the drug was called into question in 2005, when the FDA forced it to display a stringent "black box warning" about Strattera's side effects of suicidal ideation.  Children and teenagers are especially at risk; parents of a child who is taking Strattera should be on the lookout for mood swings and suicidal intentions.  Initially researched for its potential as an antidepressant, Strattera is now an alternative for patients who want a non-amphetamine-based ADHD drug.

Fast Facts

Name: Strattera
Generic: Atomoxetine
Manufacturer: Eli Lilly
Date approved: 2002
Status: Prescription Only
Approved uses: Treatment of Attention Deficit Disorder with Hyperactivity (ADHD)
Off-Label uses: Treatment of depression and anxiety; illegal use to improve concentration, especially in students
Side effects: Increased suicidal thoughts and suicide attempts among children and teens, liver damage, weight loss, impaired motor skills
Related topics: Adderall, Paxil

Looking for a Strattera lawyer in Washington, DC? Get in touch with one of our Strattera lawyers in Washington, DC now.

Strattera Not Immune From Increased Suicide Risk

It is considered by many to be a "safe" alternative to amphetamine-laced, stimulant attention-deficit disorder with hyperactivity (ADHD) drugs, but Strattera is not immune to one of ADHD... read more

View the Strattera Main Articles page here


FDA Information Related to Strattera

October 2006 Monthly Safety Labeling

What's New at CDER by Category

View the Strattera FDA Information page here


MSN Newsfeeds Related to Strattera

Shoring up Strattera

Drugs and Treatments - Paxil Oral

View the Strattera MSN Newsfeeds page here


News Articles Related to Strattera

St. John's wort may not help ADHD in children/ teens

» St. John’s Wort Not Effective for ADHD - Psych Central News

View the Strattera News Articles page here


Patents Related to Strattera

Treatment of attention-deficit/hyperactivity disorder

View the Strattera Patents page here


Useful Web Sites Related to Strattera

Anapol Schwartz - Pennsylvania Strattera Lawyers

View the Strattera Useful Web Sites page here


Wikipedia Entries Related to Strattera

Atomoxetine

Attention-deficit hyperactivity disorder

View the Strattera Wikipedia Entries page here


Books Related to Strattera

Atomoxetine warning: risk of suicidal ideation.(Behavioral Pediatrics) : An article from: Pediatric News

Methylphenidate beats atomoxetine for ADHD in head-to-head comparison.(Mental Health)(Attention-deficit hyperactivity disorder): An article from: Family Practice News

View the Strattera Books page here

Looking for a Strattera lawyer in Washington, DC? Get in touch with one of our Strattera lawyers in Washington, DC now.

AddThis Social Bookmark Button

Need A Strattera Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Click to Ask a Question


Need A Strattera Lawyer?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Click to Ask a Question